Advertisement

Latest Hypertension - High Blood Pressure News RSS Twitter

    Press ReleaseNew Wellness Team Approach Improves Diabetes Outcomes while Lowering Medication Costs An integrated wellness team approach to diabetes care is helping patients lower their prescription costs and improve their condition, according to research presented today at the American Association of Clinical Endocrinologists’ (AACE) 21st Annual Scientific & Clinical Congress
    Press ReleaseRegular Aerobic Exercise Improves Vascular Reactivity for Patients at Risk of Developing DiabetesPre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinica
    Press ReleaseSanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The LancetPARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 (Study 1003, NTC01266876) in patients with heterozygous familial hypercholesterolemia (heFH). SAR236553/REGN727 is a subcutaneously administered, fully-human antibod...
    Syndicated ContentCDC proposes expansion of hepatitis C guidelinesCDC is proposing an expansion of its current hepatitis C risk-based guidelines to include a simple, one-time blood test ?for anyone born from 1945 through 1965.
    Syndicated ContentBetter blood pressure control with antihypertensive drug comboNEW YORK (Reuters Health) - Among elderly hypertensive patients in Japan, adding a calcium channel blocker (CCB) to an angiotensin II receptor blocker (ARB) provided better blood pressure control than a doubled dose of the ARB.
    Press Release"Stem Cells Market Will Reach $7.3 Billion in 2014," Visiongain Report PredictsLondon, United Kingdom, May 26, 2012 --(PR.com)-- That market will be stimulated by new treatments and increasing use of related products in drug development. Those findings appear in Stem Cell Technologies: World Market Outlook 2012-2022, published in May 2012. Visiongain is a business information provider based in London, UK. Visiongain forecasts that the stem cells market will expand rapidly...
    Press ReleaseDiabetics and Others Sensitive to Artificial Sweetener Embrace Ultimate BeverageOXYWater contains natural sweetener without the sugar or artificial sweeteners that cause side effects for diabetics or those sensitive to phenylalanine. Columbus, OH (PRWEB) May 25, 2012 OXYWater, A new healthy drink is gaining popularity across America because it is a zero calorie, zero carb, natural fruit flavored beverage with all the good stuff and none of the bad stuff. OXYWater is a smart...
    Syndicated ContentDiabetes Treatment - Potential New TargetThe online edition of Proceedings of the National Academy of Sciences reports that Cincinnati University (UC) researchers have discovered that apolipoprotein A-IV (apoA-IV), a naturally produced protein that has the ability to reduce blood sugar leve...
    Syndicated ContentProteomic analysis of immunocamouflaged surfaces(Science in China Press) The immunocamouflage of cell surfaces by grafted polymers holds great potential in clinical medicine. In the current issue of Science China Life Sciences, researchers with the Canadian Blood Services have used proteomic analy...
    Syndicated ContentCHMP: Pradaxa benefits outweigh bleeding riskEMA's CHMP completed a review of the risk of bleeding associated with Pradaxa dabigatran from Boehringer Ingelheim GmbH (Ingelheim, Germany) and recommended updating the label of the atrial fibrillation (AF) drug to include clearer guidance on how to...
    BlogsThe Wrong Way to Stop Fake DrugsBy Roger Bate In 2007-8, when counterfeit versions of heparin, a blood-thinning drug, were shipped from China to the United States market, 149 people died. In the last few months, bogus versions of the cancer drug Avastin, apparently shipped from the...
    BioPortfolio BlogYoung Inspiring Scientists and Symptom SurveillanceThe technology giant Intel recently awarded several youngsters with awards for their innovative work in healthcare. The youngest, 15 year old Jack Andraka, has developed a pancreatic cancer diagnostic test based on the principles of diabetic blood tests. Other winners included Nicholas Schiefer, 17 years old, who researched the new phenomenon of “microsearch”. Read more here. &lsquo...
    Syndicated ContentDialysate Concentrates Used in Hemodialysis: Safety Communication - Alkali Dosing ErrorsRisk of elevated bicarbonate levels in patients undergoing hemodialysis, which can contribute to metabolic alkalosis, a significant risk factor associated with cardiopulmonary arrest, low blood pressure, hypokalemia, hypoxemia, hypercapnia, and cardi...
    Press ReleaseCarl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft SurgeryCarl Zeiss Meditec AG / Carl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft Surgery . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. INFRARED 800 and FLOW 800 Fluorescence Modules showcased at the upcoming EURAPS 2012 JENA/Germany, 25 May 2012The INFRARED 80...
    Press ReleasePfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EUPfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of pri...
    Syndicated ContentSummit Corporation shares up as starts Phase 1 trials of SMT C1100Shares in Summit Corporation (LON:SUMM) advanced 5 per cent today as it revealed it had started a phase 1 trial on its potentially breakthrough treatment for Duchenne Muscular Dystrophy. The drug discovery company said it had dosed the first cohort...
    Press ReleaseTelcare's Wireless-Enabled Blood Glucose Monitoring System Wins 2012 Triple Tree iAwardTelcare Recognized For Insight, Innovation, and Initiative in Healthcare at annual meeting of Wireless Life Sciences Alliance San Diego, CA (PRWEB) May 25, 2012 [San Diego, CA] Telcare has won the 2012 TripleTree iAward recognizing exceptional companies that demonstrate insight, innovation, and initiative with wireless solutions in the healthcare industry. The award was announced today at the 7...
    Press ReleaseBiggest Loser Contestants Reap Big Health GainsParticipants in the NBC reality program “The Biggest Loser,” who undergo an intensive, exercise-based weight loss regimen, not only benefit from significant body weight reduction but also are rewarded with substantial and rapid recovery from serious health conditions, according to a new study being presented today at the 21st Annual Scientific and Clin...
    Press ReleaseBone: An Endocrine Organ?Prior to 1964, bone was thought to be an inert, static storage depot for calcium crystal in the body. In that year, Dr. Harold Frost introduced the revolutionary hypothesis that bone was actually a very dynamic system that was constantly being remodeled in response to mechanical and gravitational stress. Today at the American Association of Clinical Endocr...
    Syndicated ContentEuropean Medicines Agency Updates Patient and Prescriber Information for PradaxaData confirm positive benefit-risk balance of anticoagulant medicine, but modifications to product information for clearer guidance needed The European Medicines Agency has recommended updating the product information for the blood thinner...
    Syndicated ContentOnyx Rises on Analyst View of Blood Cancer DrugFrom Associated Press (May 24, 2012) NEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug...
    ArticleNews and press releases: European Medicines Agency updates patient and prescriber information for PradaxaThe European Medicines Agency has recommended updating the product information for the blood thinner Pradaxa, to give clearer guidance to doctors and patients on how to reduce and manage the risk of bleeding associated with the anticoagulant medicine...
    Syndicated ContentTissue Regenix extends development partnership with NHSRegenerative tissue specialist Tissue Regenix (LON:TRX) has agreed a major expansion of its development partnership with the NHS’s blood and transplant unit, NHSBT. The company, which has pioneered a technology that can swap worn out or damage...
    Press ReleaseBaxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing DialysisBaxter International Inc. (NYSE: BAX) today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis (PD) regimen favorably impacted metabolic measures important for end-stage renal disease (ESRD) patients with diabetes, including blood glucose (sugar) control and selected lipids (fats and chol...
    Press ReleaseAmerican Diabetes Wholesale To Offer 10% Discount Off All Orders During Memorial Day WeekendAmerican Diabetes Wholesale announces their Memorial Day Sale. Pompano Beach, FL (PRWEB) May 25, 2012 American Diabetes Wholesale announces their sale to honor Memorial Day giving customers a 10% discount on all products purchased between May 25th and May 28th at http://www.americandiabeteswholesale.com. The sale is a 4-day sale and will be applicable to all orders processed through the company...
buy Hypertension - High Blood Pressure market research data and corporate reports now Advertisement

News Categories

Advertisement